nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—ACHE—Irinotecan—hematologic cancer	0.0549	0.0961	CbGbCtD
Donepezil—CYP2C9—Bexarotene—hematologic cancer	0.0309	0.054	CbGbCtD
Donepezil—CYP2D6—Lomustine—hematologic cancer	0.0262	0.0459	CbGbCtD
Donepezil—CYP2C9—Idarubicin—hematologic cancer	0.0256	0.0447	CbGbCtD
Donepezil—CYP2D6—Idarubicin—hematologic cancer	0.0234	0.0409	CbGbCtD
Donepezil—CYP2D6—Hydroxyurea—hematologic cancer	0.0199	0.0348	CbGbCtD
Donepezil—CYP2C9—Bortezomib—hematologic cancer	0.0189	0.0331	CbGbCtD
Donepezil—CYP3A4—Bexarotene—hematologic cancer	0.0179	0.0314	CbGbCtD
Donepezil—CYP2D6—Bortezomib—hematologic cancer	0.0173	0.0302	CbGbCtD
Donepezil—CYP3A4—Busulfan—hematologic cancer	0.0167	0.0292	CbGbCtD
Donepezil—CYP3A4—Lomustine—hematologic cancer	0.0167	0.0292	CbGbCtD
Donepezil—CYP2C9—Thalidomide—hematologic cancer	0.0165	0.0288	CbGbCtD
Donepezil—CYP2C9—Teniposide—hematologic cancer	0.0157	0.0275	CbGbCtD
Donepezil—CYP3A4—Thiotepa—hematologic cancer	0.0149	0.026	CbGbCtD
Donepezil—CYP2C9—Ifosfamide—hematologic cancer	0.0145	0.0254	CbGbCtD
Donepezil—CYP2C9—Imatinib—hematologic cancer	0.0139	0.0242	CbGbCtD
Donepezil—CYP2D6—Imatinib—hematologic cancer	0.0127	0.0222	CbGbCtD
Donepezil—CYP2C9—Nilotinib—hematologic cancer	0.0126	0.022	CbGbCtD
Donepezil—CYP3A4—Methoxsalen—hematologic cancer	0.0116	0.0202	CbGbCtD
Donepezil—CYP2D6—Nilotinib—hematologic cancer	0.0115	0.0201	CbGbCtD
Donepezil—CYP2D6—Vinorelbine—hematologic cancer	0.0114	0.02	CbGbCtD
Donepezil—CYP3A4—Bortezomib—hematologic cancer	0.011	0.0192	CbGbCtD
Donepezil—CYP3A4—Daunorubicin—hematologic cancer	0.0105	0.0184	CbGbCtD
Donepezil—CYP3A4—Cytarabine—hematologic cancer	0.00928	0.0162	CbGbCtD
Donepezil—CYP3A4—Teniposide—hematologic cancer	0.00914	0.016	CbGbCtD
Donepezil—CYP3A4—Ifosfamide—hematologic cancer	0.00843	0.0147	CbGbCtD
Donepezil—CYP3A4—Imatinib—hematologic cancer	0.00806	0.0141	CbGbCtD
Donepezil—CYP3A4—Ruxolitinib—hematologic cancer	0.00759	0.0133	CbGbCtD
Donepezil—CYP3A4—Nilotinib—hematologic cancer	0.00732	0.0128	CbGbCtD
Donepezil—CYP3A4—Vinorelbine—hematologic cancer	0.00726	0.0127	CbGbCtD
Donepezil—CYP2C9—Cisplatin—hematologic cancer	0.00706	0.0123	CbGbCtD
Donepezil—CYP2D6—Vinblastine—hematologic cancer	0.00704	0.0123	CbGbCtD
Donepezil—CYP3A4—Triamcinolone—hematologic cancer	0.00664	0.0116	CbGbCtD
Donepezil—CYP3A4—Dasatinib—hematologic cancer	0.00647	0.0113	CbGbCtD
Donepezil—CYP3A4—Mitoxantrone—hematologic cancer	0.00639	0.0112	CbGbCtD
Donepezil—CYP2C9—Dexamethasone—hematologic cancer	0.0057	0.00997	CbGbCtD
Donepezil—CYP3A4—Betamethasone—hematologic cancer	0.0057	0.00996	CbGbCtD
Donepezil—CYP3A4—Prednisolone—hematologic cancer	0.00562	0.00983	CbGbCtD
Donepezil—CYP3A4—Prednisone—hematologic cancer	0.00531	0.00928	CbGbCtD
Donepezil—CYP2D6—Dexamethasone—hematologic cancer	0.00521	0.00911	CbGbCtD
Donepezil—CYP3A4—Irinotecan—hematologic cancer	0.00503	0.0088	CbGbCtD
Donepezil—CYP3A4—Vinblastine—hematologic cancer	0.00447	0.00782	CbGbCtD
Donepezil—CYP3A4—Vincristine—hematologic cancer	0.0044	0.00769	CbGbCtD
Donepezil—CYP2D6—Doxorubicin—hematologic cancer	0.00432	0.00756	CbGbCtD
Donepezil—CYP3A4—Etoposide—hematologic cancer	0.00403	0.00705	CbGbCtD
Donepezil—CYP3A4—Dexamethasone—hematologic cancer	0.00331	0.0058	CbGbCtD
Donepezil—CYP3A4—Doxorubicin—hematologic cancer	0.00275	0.00481	CbGbCtD
Donepezil—HRH3—hematopoietic system—hematologic cancer	0.00244	0.201	CbGeAlD
Donepezil—HRH3—blood—hematologic cancer	0.00162	0.133	CbGeAlD
Donepezil—ACHE—testis—hematologic cancer	0.000724	0.0597	CbGeAlD
Donepezil—SIGMAR1—blood—hematologic cancer	0.000587	0.0484	CbGeAlD
Donepezil—CYP2C9—hematopoietic system—hematologic cancer	0.000573	0.0473	CbGeAlD
Donepezil—SIGMAR1—bone marrow—hematologic cancer	0.000568	0.0469	CbGeAlD
Donepezil—ACHE—lymph node—hematologic cancer	0.000525	0.0433	CbGeAlD
Donepezil—SIGMAR1—lung—hematologic cancer	0.000515	0.0425	CbGeAlD
Donepezil—SIGMAR1—testis—hematologic cancer	0.000486	0.0401	CbGeAlD
Donepezil—HTR2A—hematopoietic system—hematologic cancer	0.000472	0.039	CbGeAlD
Donepezil—CYP3A4—hematopoietic system—hematologic cancer	0.000437	0.0361	CbGeAlD
Donepezil—CYP2D6—hematopoietic system—hematologic cancer	0.00043	0.0355	CbGeAlD
Donepezil—CYP2C9—blood—hematologic cancer	0.00038	0.0313	CbGeAlD
Donepezil—HTR2A—gonad—hematologic cancer	0.000359	0.0296	CbGeAlD
Donepezil—SIGMAR1—lymph node—hematologic cancer	0.000352	0.029	CbGeAlD
Donepezil—HTR2A—blood—hematologic cancer	0.000313	0.0258	CbGeAlD
Donepezil—CYP3A4—blood—hematologic cancer	0.00029	0.0239	CbGeAlD
Donepezil—CYP2D6—blood—hematologic cancer	0.000285	0.0235	CbGeAlD
Donepezil—HTR2A—lung—hematologic cancer	0.000274	0.0226	CbGeAlD
Donepezil—HTR2A—testis—hematologic cancer	0.000259	0.0213	CbGeAlD
Donepezil—CYP2D6—testis—hematologic cancer	0.000236	0.0194	CbGeAlD
Donepezil—Visual impairment—Doxorubicin—hematologic cancer	2e-05	5.69e-05	CcSEcCtD
Donepezil—Nervous system disorder—Prednisone—hematologic cancer	2e-05	5.68e-05	CcSEcCtD
Donepezil—Alopecia—Epirubicin—hematologic cancer	1.98e-05	5.64e-05	CcSEcCtD
Donepezil—Nausea—Gemcitabine—hematologic cancer	1.97e-05	5.62e-05	CcSEcCtD
Donepezil—Vomiting—Cisplatin—hematologic cancer	1.97e-05	5.61e-05	CcSEcCtD
Donepezil—Hyperhidrosis—Prednisone—hematologic cancer	1.97e-05	5.6e-05	CcSEcCtD
Donepezil—Vision blurred—Methotrexate—hematologic cancer	1.96e-05	5.59e-05	CcSEcCtD
Donepezil—Mental disorder—Epirubicin—hematologic cancer	1.96e-05	5.59e-05	CcSEcCtD
Donepezil—Rash—Cisplatin—hematologic cancer	1.95e-05	5.56e-05	CcSEcCtD
Donepezil—Dermatitis—Cisplatin—hematologic cancer	1.95e-05	5.56e-05	CcSEcCtD
Donepezil—Erythema—Epirubicin—hematologic cancer	1.95e-05	5.55e-05	CcSEcCtD
Donepezil—Malnutrition—Epirubicin—hematologic cancer	1.95e-05	5.55e-05	CcSEcCtD
Donepezil—Diarrhoea—Etoposide—hematologic cancer	1.94e-05	5.53e-05	CcSEcCtD
Donepezil—Anorexia—Prednisone—hematologic cancer	1.94e-05	5.52e-05	CcSEcCtD
Donepezil—Ill-defined disorder—Methotrexate—hematologic cancer	1.93e-05	5.51e-05	CcSEcCtD
Donepezil—Tinnitus—Doxorubicin—hematologic cancer	1.93e-05	5.5e-05	CcSEcCtD
Donepezil—Anaemia—Methotrexate—hematologic cancer	1.93e-05	5.48e-05	CcSEcCtD
Donepezil—Feeling abnormal—Betamethasone—hematologic cancer	1.93e-05	5.48e-05	CcSEcCtD
Donepezil—Feeling abnormal—Dexamethasone—hematologic cancer	1.93e-05	5.48e-05	CcSEcCtD
Donepezil—Flatulence—Epirubicin—hematologic cancer	1.92e-05	5.47e-05	CcSEcCtD
Donepezil—Tension—Epirubicin—hematologic cancer	1.91e-05	5.45e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Betamethasone—hematologic cancer	1.91e-05	5.44e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.91e-05	5.44e-05	CcSEcCtD
Donepezil—Dysgeusia—Epirubicin—hematologic cancer	1.91e-05	5.44e-05	CcSEcCtD
Donepezil—Hypersensitivity—Triamcinolone—hematologic cancer	1.9e-05	5.4e-05	CcSEcCtD
Donepezil—Nervousness—Epirubicin—hematologic cancer	1.89e-05	5.39e-05	CcSEcCtD
Donepezil—Back pain—Epirubicin—hematologic cancer	1.89e-05	5.37e-05	CcSEcCtD
Donepezil—Malaise—Methotrexate—hematologic cancer	1.88e-05	5.35e-05	CcSEcCtD
Donepezil—Dizziness—Etoposide—hematologic cancer	1.88e-05	5.35e-05	CcSEcCtD
Donepezil—Muscle spasms—Epirubicin—hematologic cancer	1.87e-05	5.34e-05	CcSEcCtD
Donepezil—Vertigo—Methotrexate—hematologic cancer	1.87e-05	5.33e-05	CcSEcCtD
Donepezil—Chills—Doxorubicin—hematologic cancer	1.86e-05	5.3e-05	CcSEcCtD
Donepezil—Urticaria—Betamethasone—hematologic cancer	1.86e-05	5.29e-05	CcSEcCtD
Donepezil—Urticaria—Dexamethasone—hematologic cancer	1.86e-05	5.29e-05	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.85e-05	5.28e-05	CcSEcCtD
Donepezil—Dizziness—Prednisolone—hematologic cancer	1.85e-05	5.27e-05	CcSEcCtD
Donepezil—Arrhythmia—Doxorubicin—hematologic cancer	1.85e-05	5.27e-05	CcSEcCtD
Donepezil—Asthenia—Triamcinolone—hematologic cancer	1.85e-05	5.26e-05	CcSEcCtD
Donepezil—Body temperature increased—Betamethasone—hematologic cancer	1.85e-05	5.26e-05	CcSEcCtD
Donepezil—Abdominal pain—Dexamethasone—hematologic cancer	1.85e-05	5.26e-05	CcSEcCtD
Donepezil—Abdominal pain—Betamethasone—hematologic cancer	1.85e-05	5.26e-05	CcSEcCtD
Donepezil—Body temperature increased—Dexamethasone—hematologic cancer	1.85e-05	5.26e-05	CcSEcCtD
Donepezil—Nausea—Cisplatin—hematologic cancer	1.84e-05	5.24e-05	CcSEcCtD
Donepezil—Insomnia—Prednisone—hematologic cancer	1.84e-05	5.24e-05	CcSEcCtD
Donepezil—Vision blurred—Epirubicin—hematologic cancer	1.84e-05	5.23e-05	CcSEcCtD
Donepezil—Alopecia—Doxorubicin—hematologic cancer	1.83e-05	5.22e-05	CcSEcCtD
Donepezil—Paraesthesia—Prednisone—hematologic cancer	1.83e-05	5.2e-05	CcSEcCtD
Donepezil—Pruritus—Triamcinolone—hematologic cancer	1.82e-05	5.19e-05	CcSEcCtD
Donepezil—Cough—Methotrexate—hematologic cancer	1.82e-05	5.18e-05	CcSEcCtD
Donepezil—Mental disorder—Doxorubicin—hematologic cancer	1.82e-05	5.17e-05	CcSEcCtD
Donepezil—Ill-defined disorder—Epirubicin—hematologic cancer	1.81e-05	5.15e-05	CcSEcCtD
Donepezil—Convulsion—Methotrexate—hematologic cancer	1.8e-05	5.14e-05	CcSEcCtD
Donepezil—Vomiting—Etoposide—hematologic cancer	1.8e-05	5.14e-05	CcSEcCtD
Donepezil—Malnutrition—Doxorubicin—hematologic cancer	1.8e-05	5.14e-05	CcSEcCtD
Donepezil—Erythema—Doxorubicin—hematologic cancer	1.8e-05	5.14e-05	CcSEcCtD
Donepezil—Anaemia—Epirubicin—hematologic cancer	1.8e-05	5.13e-05	CcSEcCtD
Donepezil—Agitation—Epirubicin—hematologic cancer	1.79e-05	5.1e-05	CcSEcCtD
Donepezil—Dyspepsia—Prednisone—hematologic cancer	1.79e-05	5.1e-05	CcSEcCtD
Donepezil—Rash—Etoposide—hematologic cancer	1.79e-05	5.1e-05	CcSEcCtD
Donepezil—Dermatitis—Etoposide—hematologic cancer	1.79e-05	5.09e-05	CcSEcCtD
Donepezil—Headache—Etoposide—hematologic cancer	1.78e-05	5.07e-05	CcSEcCtD
Donepezil—Flatulence—Doxorubicin—hematologic cancer	1.78e-05	5.06e-05	CcSEcCtD
Donepezil—Chest pain—Methotrexate—hematologic cancer	1.77e-05	5.05e-05	CcSEcCtD
Donepezil—Myalgia—Methotrexate—hematologic cancer	1.77e-05	5.05e-05	CcSEcCtD
Donepezil—Arthralgia—Methotrexate—hematologic cancer	1.77e-05	5.05e-05	CcSEcCtD
Donepezil—Tension—Doxorubicin—hematologic cancer	1.77e-05	5.04e-05	CcSEcCtD
Donepezil—Decreased appetite—Prednisone—hematologic cancer	1.77e-05	5.04e-05	CcSEcCtD
Donepezil—Dysgeusia—Doxorubicin—hematologic cancer	1.77e-05	5.03e-05	CcSEcCtD
Donepezil—Rash—Prednisolone—hematologic cancer	1.77e-05	5.03e-05	CcSEcCtD
Donepezil—Dermatitis—Prednisolone—hematologic cancer	1.76e-05	5.02e-05	CcSEcCtD
Donepezil—Malaise—Epirubicin—hematologic cancer	1.76e-05	5.01e-05	CcSEcCtD
Donepezil—Fatigue—Prednisone—hematologic cancer	1.75e-05	5e-05	CcSEcCtD
Donepezil—Headache—Prednisolone—hematologic cancer	1.75e-05	5e-05	CcSEcCtD
Donepezil—Discomfort—Methotrexate—hematologic cancer	1.75e-05	4.99e-05	CcSEcCtD
Donepezil—Nervousness—Doxorubicin—hematologic cancer	1.75e-05	4.99e-05	CcSEcCtD
Donepezil—Vertigo—Epirubicin—hematologic cancer	1.75e-05	4.99e-05	CcSEcCtD
Donepezil—Syncope—Epirubicin—hematologic cancer	1.75e-05	4.98e-05	CcSEcCtD
Donepezil—Back pain—Doxorubicin—hematologic cancer	1.74e-05	4.97e-05	CcSEcCtD
Donepezil—Constipation—Prednisone—hematologic cancer	1.74e-05	4.96e-05	CcSEcCtD
Donepezil—Muscle spasms—Doxorubicin—hematologic cancer	1.73e-05	4.94e-05	CcSEcCtD
Donepezil—Confusional state—Methotrexate—hematologic cancer	1.71e-05	4.88e-05	CcSEcCtD
Donepezil—Loss of consciousness—Epirubicin—hematologic cancer	1.71e-05	4.88e-05	CcSEcCtD
Donepezil—Dizziness—Triamcinolone—hematologic cancer	1.7e-05	4.85e-05	CcSEcCtD
Donepezil—Cough—Epirubicin—hematologic cancer	1.7e-05	4.85e-05	CcSEcCtD
Donepezil—Vision blurred—Doxorubicin—hematologic cancer	1.7e-05	4.84e-05	CcSEcCtD
Donepezil—Convulsion—Epirubicin—hematologic cancer	1.69e-05	4.81e-05	CcSEcCtD
Donepezil—Infection—Methotrexate—hematologic cancer	1.69e-05	4.81e-05	CcSEcCtD
Donepezil—Nausea—Etoposide—hematologic cancer	1.69e-05	4.8e-05	CcSEcCtD
Donepezil—Hypertension—Epirubicin—hematologic cancer	1.68e-05	4.79e-05	CcSEcCtD
Donepezil—Feeling abnormal—Prednisone—hematologic cancer	1.68e-05	4.78e-05	CcSEcCtD
Donepezil—Asthenia—Betamethasone—hematologic cancer	1.68e-05	4.77e-05	CcSEcCtD
Donepezil—Asthenia—Dexamethasone—hematologic cancer	1.68e-05	4.77e-05	CcSEcCtD
Donepezil—Ill-defined disorder—Doxorubicin—hematologic cancer	1.67e-05	4.77e-05	CcSEcCtD
Donepezil—Nervous system disorder—Methotrexate—hematologic cancer	1.67e-05	4.75e-05	CcSEcCtD
Donepezil—Anaemia—Doxorubicin—hematologic cancer	1.67e-05	4.75e-05	CcSEcCtD
Donepezil—Thrombocytopenia—Methotrexate—hematologic cancer	1.66e-05	4.74e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Prednisone—hematologic cancer	1.66e-05	4.74e-05	CcSEcCtD
Donepezil—Nausea—Prednisolone—hematologic cancer	1.66e-05	4.74e-05	CcSEcCtD
Donepezil—Arthralgia—Epirubicin—hematologic cancer	1.66e-05	4.73e-05	CcSEcCtD
Donepezil—Chest pain—Epirubicin—hematologic cancer	1.66e-05	4.73e-05	CcSEcCtD
Donepezil—Myalgia—Epirubicin—hematologic cancer	1.66e-05	4.73e-05	CcSEcCtD
Donepezil—Agitation—Doxorubicin—hematologic cancer	1.66e-05	4.72e-05	CcSEcCtD
Donepezil—Anxiety—Epirubicin—hematologic cancer	1.65e-05	4.71e-05	CcSEcCtD
Donepezil—Pruritus—Betamethasone—hematologic cancer	1.65e-05	4.71e-05	CcSEcCtD
Donepezil—Pruritus—Dexamethasone—hematologic cancer	1.65e-05	4.71e-05	CcSEcCtD
Donepezil—Hyperhidrosis—Methotrexate—hematologic cancer	1.64e-05	4.68e-05	CcSEcCtD
Donepezil—Discomfort—Epirubicin—hematologic cancer	1.64e-05	4.67e-05	CcSEcCtD
Donepezil—Vomiting—Triamcinolone—hematologic cancer	1.64e-05	4.66e-05	CcSEcCtD
Donepezil—Malaise—Doxorubicin—hematologic cancer	1.63e-05	4.63e-05	CcSEcCtD
Donepezil—Rash—Triamcinolone—hematologic cancer	1.62e-05	4.62e-05	CcSEcCtD
Donepezil—Dry mouth—Epirubicin—hematologic cancer	1.62e-05	4.62e-05	CcSEcCtD
Donepezil—Dermatitis—Triamcinolone—hematologic cancer	1.62e-05	4.62e-05	CcSEcCtD
Donepezil—Vertigo—Doxorubicin—hematologic cancer	1.62e-05	4.62e-05	CcSEcCtD
Donepezil—Anorexia—Methotrexate—hematologic cancer	1.62e-05	4.62e-05	CcSEcCtD
Donepezil—Syncope—Doxorubicin—hematologic cancer	1.62e-05	4.61e-05	CcSEcCtD
Donepezil—Urticaria—Prednisone—hematologic cancer	1.62e-05	4.6e-05	CcSEcCtD
Donepezil—Headache—Triamcinolone—hematologic cancer	1.61e-05	4.59e-05	CcSEcCtD
Donepezil—Abdominal pain—Prednisone—hematologic cancer	1.61e-05	4.58e-05	CcSEcCtD
Donepezil—Body temperature increased—Prednisone—hematologic cancer	1.61e-05	4.58e-05	CcSEcCtD
Donepezil—Confusional state—Epirubicin—hematologic cancer	1.6e-05	4.57e-05	CcSEcCtD
Donepezil—Diarrhoea—Dexamethasone—hematologic cancer	1.6e-05	4.55e-05	CcSEcCtD
Donepezil—Diarrhoea—Betamethasone—hematologic cancer	1.6e-05	4.55e-05	CcSEcCtD
Donepezil—Oedema—Epirubicin—hematologic cancer	1.59e-05	4.53e-05	CcSEcCtD
Donepezil—Hypotension—Methotrexate—hematologic cancer	1.59e-05	4.53e-05	CcSEcCtD
Donepezil—Loss of consciousness—Doxorubicin—hematologic cancer	1.59e-05	4.52e-05	CcSEcCtD
Donepezil—Infection—Epirubicin—hematologic cancer	1.58e-05	4.5e-05	CcSEcCtD
Donepezil—Cough—Doxorubicin—hematologic cancer	1.57e-05	4.48e-05	CcSEcCtD
Donepezil—Shock—Epirubicin—hematologic cancer	1.57e-05	4.46e-05	CcSEcCtD
Donepezil—Convulsion—Doxorubicin—hematologic cancer	1.56e-05	4.45e-05	CcSEcCtD
Donepezil—Nervous system disorder—Epirubicin—hematologic cancer	1.56e-05	4.44e-05	CcSEcCtD
Donepezil—Thrombocytopenia—Epirubicin—hematologic cancer	1.56e-05	4.44e-05	CcSEcCtD
Donepezil—Hypertension—Doxorubicin—hematologic cancer	1.56e-05	4.44e-05	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.55e-05	4.41e-05	CcSEcCtD
Donepezil—Dizziness—Betamethasone—hematologic cancer	1.54e-05	4.4e-05	CcSEcCtD
Donepezil—Dizziness—Dexamethasone—hematologic cancer	1.54e-05	4.4e-05	CcSEcCtD
Donepezil—Hyperhidrosis—Epirubicin—hematologic cancer	1.54e-05	4.38e-05	CcSEcCtD
Donepezil—Insomnia—Methotrexate—hematologic cancer	1.54e-05	4.38e-05	CcSEcCtD
Donepezil—Chest pain—Doxorubicin—hematologic cancer	1.54e-05	4.37e-05	CcSEcCtD
Donepezil—Arthralgia—Doxorubicin—hematologic cancer	1.54e-05	4.37e-05	CcSEcCtD
Donepezil—Myalgia—Doxorubicin—hematologic cancer	1.54e-05	4.37e-05	CcSEcCtD
Donepezil—Anxiety—Doxorubicin—hematologic cancer	1.53e-05	4.36e-05	CcSEcCtD
Donepezil—Nausea—Triamcinolone—hematologic cancer	1.53e-05	4.36e-05	CcSEcCtD
Donepezil—Paraesthesia—Methotrexate—hematologic cancer	1.53e-05	4.35e-05	CcSEcCtD
Donepezil—Discomfort—Doxorubicin—hematologic cancer	1.52e-05	4.32e-05	CcSEcCtD
Donepezil—Anorexia—Epirubicin—hematologic cancer	1.52e-05	4.32e-05	CcSEcCtD
Donepezil—Dyspnoea—Methotrexate—hematologic cancer	1.52e-05	4.32e-05	CcSEcCtD
Donepezil—Somnolence—Methotrexate—hematologic cancer	1.51e-05	4.31e-05	CcSEcCtD
Donepezil—Dry mouth—Doxorubicin—hematologic cancer	1.5e-05	4.28e-05	CcSEcCtD
Donepezil—Hypersensitivity—Prednisone—hematologic cancer	1.5e-05	4.27e-05	CcSEcCtD
Donepezil—Dyspepsia—Methotrexate—hematologic cancer	1.5e-05	4.26e-05	CcSEcCtD
Donepezil—Hypotension—Epirubicin—hematologic cancer	1.49e-05	4.24e-05	CcSEcCtD
Donepezil—Vomiting—Betamethasone—hematologic cancer	1.49e-05	4.23e-05	CcSEcCtD
Donepezil—Vomiting—Dexamethasone—hematologic cancer	1.49e-05	4.23e-05	CcSEcCtD
Donepezil—Confusional state—Doxorubicin—hematologic cancer	1.48e-05	4.23e-05	CcSEcCtD
Donepezil—Decreased appetite—Methotrexate—hematologic cancer	1.48e-05	4.21e-05	CcSEcCtD
Donepezil—Rash—Dexamethasone—hematologic cancer	1.47e-05	4.2e-05	CcSEcCtD
Donepezil—Rash—Betamethasone—hematologic cancer	1.47e-05	4.2e-05	CcSEcCtD
Donepezil—Oedema—Doxorubicin—hematologic cancer	1.47e-05	4.19e-05	CcSEcCtD
Donepezil—Dermatitis—Dexamethasone—hematologic cancer	1.47e-05	4.19e-05	CcSEcCtD
Donepezil—Dermatitis—Betamethasone—hematologic cancer	1.47e-05	4.19e-05	CcSEcCtD
Donepezil—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.47e-05	4.18e-05	CcSEcCtD
Donepezil—Fatigue—Methotrexate—hematologic cancer	1.47e-05	4.18e-05	CcSEcCtD
Donepezil—Headache—Betamethasone—hematologic cancer	1.46e-05	4.17e-05	CcSEcCtD
Donepezil—Headache—Dexamethasone—hematologic cancer	1.46e-05	4.17e-05	CcSEcCtD
Donepezil—Infection—Doxorubicin—hematologic cancer	1.46e-05	4.17e-05	CcSEcCtD
Donepezil—Asthenia—Prednisone—hematologic cancer	1.46e-05	4.16e-05	CcSEcCtD
Donepezil—Pain—Methotrexate—hematologic cancer	1.45e-05	4.14e-05	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.45e-05	4.13e-05	CcSEcCtD
Donepezil—Shock—Doxorubicin—hematologic cancer	1.45e-05	4.13e-05	CcSEcCtD
Donepezil—Nervous system disorder—Doxorubicin—hematologic cancer	1.44e-05	4.11e-05	CcSEcCtD
Donepezil—Thrombocytopenia—Doxorubicin—hematologic cancer	1.44e-05	4.11e-05	CcSEcCtD
Donepezil—Pruritus—Prednisone—hematologic cancer	1.44e-05	4.1e-05	CcSEcCtD
Donepezil—Insomnia—Epirubicin—hematologic cancer	1.44e-05	4.1e-05	CcSEcCtD
Donepezil—Paraesthesia—Epirubicin—hematologic cancer	1.43e-05	4.07e-05	CcSEcCtD
Donepezil—Hyperhidrosis—Doxorubicin—hematologic cancer	1.42e-05	4.05e-05	CcSEcCtD
Donepezil—Dyspnoea—Epirubicin—hematologic cancer	1.42e-05	4.04e-05	CcSEcCtD
Donepezil—Somnolence—Epirubicin—hematologic cancer	1.41e-05	4.03e-05	CcSEcCtD
Donepezil—Anorexia—Doxorubicin—hematologic cancer	1.4e-05	4e-05	CcSEcCtD
Donepezil—Feeling abnormal—Methotrexate—hematologic cancer	1.4e-05	3.99e-05	CcSEcCtD
Donepezil—Dyspepsia—Epirubicin—hematologic cancer	1.4e-05	3.99e-05	CcSEcCtD
Donepezil—Diarrhoea—Prednisone—hematologic cancer	1.39e-05	3.97e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Methotrexate—hematologic cancer	1.39e-05	3.96e-05	CcSEcCtD
Donepezil—Nausea—Dexamethasone—hematologic cancer	1.39e-05	3.95e-05	CcSEcCtD
Donepezil—Nausea—Betamethasone—hematologic cancer	1.39e-05	3.95e-05	CcSEcCtD
Donepezil—Decreased appetite—Epirubicin—hematologic cancer	1.38e-05	3.94e-05	CcSEcCtD
Donepezil—Hypotension—Doxorubicin—hematologic cancer	1.38e-05	3.92e-05	CcSEcCtD
Donepezil—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.37e-05	3.91e-05	CcSEcCtD
Donepezil—Fatigue—Epirubicin—hematologic cancer	1.37e-05	3.91e-05	CcSEcCtD
Donepezil—Pain—Epirubicin—hematologic cancer	1.36e-05	3.88e-05	CcSEcCtD
Donepezil—Constipation—Epirubicin—hematologic cancer	1.36e-05	3.88e-05	CcSEcCtD
Donepezil—Urticaria—Methotrexate—hematologic cancer	1.35e-05	3.85e-05	CcSEcCtD
Donepezil—Dizziness—Prednisone—hematologic cancer	1.35e-05	3.83e-05	CcSEcCtD
Donepezil—Abdominal pain—Methotrexate—hematologic cancer	1.34e-05	3.83e-05	CcSEcCtD
Donepezil—Body temperature increased—Methotrexate—hematologic cancer	1.34e-05	3.83e-05	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.34e-05	3.82e-05	CcSEcCtD
Donepezil—Insomnia—Doxorubicin—hematologic cancer	1.33e-05	3.79e-05	CcSEcCtD
Donepezil—Paraesthesia—Doxorubicin—hematologic cancer	1.32e-05	3.77e-05	CcSEcCtD
Donepezil—Dyspnoea—Doxorubicin—hematologic cancer	1.31e-05	3.74e-05	CcSEcCtD
Donepezil—Feeling abnormal—Epirubicin—hematologic cancer	1.31e-05	3.73e-05	CcSEcCtD
Donepezil—Somnolence—Doxorubicin—hematologic cancer	1.31e-05	3.73e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Epirubicin—hematologic cancer	1.3e-05	3.71e-05	CcSEcCtD
Donepezil—Dyspepsia—Doxorubicin—hematologic cancer	1.3e-05	3.69e-05	CcSEcCtD
Donepezil—Vomiting—Prednisone—hematologic cancer	1.29e-05	3.68e-05	CcSEcCtD
Donepezil—Rash—Prednisone—hematologic cancer	1.28e-05	3.65e-05	CcSEcCtD
Donepezil—Dermatitis—Prednisone—hematologic cancer	1.28e-05	3.65e-05	CcSEcCtD
Donepezil—Decreased appetite—Doxorubicin—hematologic cancer	1.28e-05	3.65e-05	CcSEcCtD
Donepezil—Headache—Prednisone—hematologic cancer	1.27e-05	3.63e-05	CcSEcCtD
Donepezil—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.27e-05	3.62e-05	CcSEcCtD
Donepezil—Fatigue—Doxorubicin—hematologic cancer	1.27e-05	3.62e-05	CcSEcCtD
Donepezil—Urticaria—Epirubicin—hematologic cancer	1.26e-05	3.6e-05	CcSEcCtD
Donepezil—Constipation—Doxorubicin—hematologic cancer	1.26e-05	3.59e-05	CcSEcCtD
Donepezil—Pain—Doxorubicin—hematologic cancer	1.26e-05	3.59e-05	CcSEcCtD
Donepezil—Abdominal pain—Epirubicin—hematologic cancer	1.26e-05	3.58e-05	CcSEcCtD
Donepezil—Body temperature increased—Epirubicin—hematologic cancer	1.26e-05	3.58e-05	CcSEcCtD
Donepezil—Hypersensitivity—Methotrexate—hematologic cancer	1.25e-05	3.57e-05	CcSEcCtD
Donepezil—Asthenia—Methotrexate—hematologic cancer	1.22e-05	3.47e-05	CcSEcCtD
Donepezil—Feeling abnormal—Doxorubicin—hematologic cancer	1.21e-05	3.46e-05	CcSEcCtD
Donepezil—Nausea—Prednisone—hematologic cancer	1.21e-05	3.44e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.2e-05	3.43e-05	CcSEcCtD
Donepezil—Pruritus—Methotrexate—hematologic cancer	1.2e-05	3.43e-05	CcSEcCtD
Donepezil—Hypersensitivity—Epirubicin—hematologic cancer	1.17e-05	3.34e-05	CcSEcCtD
Donepezil—Urticaria—Doxorubicin—hematologic cancer	1.17e-05	3.33e-05	CcSEcCtD
Donepezil—Body temperature increased—Doxorubicin—hematologic cancer	1.16e-05	3.32e-05	CcSEcCtD
Donepezil—Abdominal pain—Doxorubicin—hematologic cancer	1.16e-05	3.32e-05	CcSEcCtD
Donepezil—Diarrhoea—Methotrexate—hematologic cancer	1.16e-05	3.31e-05	CcSEcCtD
Donepezil—Asthenia—Epirubicin—hematologic cancer	1.14e-05	3.25e-05	CcSEcCtD
Donepezil—Pruritus—Epirubicin—hematologic cancer	1.13e-05	3.21e-05	CcSEcCtD
Donepezil—Dizziness—Methotrexate—hematologic cancer	1.12e-05	3.2e-05	CcSEcCtD
Donepezil—Diarrhoea—Epirubicin—hematologic cancer	1.09e-05	3.1e-05	CcSEcCtD
Donepezil—Hypersensitivity—Doxorubicin—hematologic cancer	1.08e-05	3.09e-05	CcSEcCtD
Donepezil—Vomiting—Methotrexate—hematologic cancer	1.08e-05	3.08e-05	CcSEcCtD
Donepezil—Rash—Methotrexate—hematologic cancer	1.07e-05	3.05e-05	CcSEcCtD
Donepezil—Dermatitis—Methotrexate—hematologic cancer	1.07e-05	3.05e-05	CcSEcCtD
Donepezil—Headache—Methotrexate—hematologic cancer	1.07e-05	3.03e-05	CcSEcCtD
Donepezil—Asthenia—Doxorubicin—hematologic cancer	1.06e-05	3.01e-05	CcSEcCtD
Donepezil—Dizziness—Epirubicin—hematologic cancer	1.05e-05	3e-05	CcSEcCtD
Donepezil—Pruritus—Doxorubicin—hematologic cancer	1.04e-05	2.97e-05	CcSEcCtD
Donepezil—Vomiting—Epirubicin—hematologic cancer	1.01e-05	2.88e-05	CcSEcCtD
Donepezil—Nausea—Methotrexate—hematologic cancer	1.01e-05	2.88e-05	CcSEcCtD
Donepezil—Diarrhoea—Doxorubicin—hematologic cancer	1.01e-05	2.87e-05	CcSEcCtD
Donepezil—Rash—Epirubicin—hematologic cancer	1e-05	2.86e-05	CcSEcCtD
Donepezil—Dermatitis—Epirubicin—hematologic cancer	1e-05	2.86e-05	CcSEcCtD
Donepezil—Headache—Epirubicin—hematologic cancer	9.97e-06	2.84e-05	CcSEcCtD
Donepezil—Dizziness—Doxorubicin—hematologic cancer	9.74e-06	2.77e-05	CcSEcCtD
Donepezil—CYP2C9—Metabolism—ABCC3—hematologic cancer	9.48e-06	0.000146	CbGpPWpGaD
Donepezil—Nausea—Epirubicin—hematologic cancer	9.45e-06	2.69e-05	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—EP300—hematologic cancer	9.44e-06	0.000145	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PRKCZ—hematologic cancer	9.43e-06	0.000145	CbGpPWpGaD
Donepezil—Vomiting—Doxorubicin—hematologic cancer	9.36e-06	2.67e-05	CcSEcCtD
Donepezil—CYP2D6—Metabolism—SPHK1—hematologic cancer	9.36e-06	0.000144	CbGpPWpGaD
Donepezil—Rash—Doxorubicin—hematologic cancer	9.28e-06	2.64e-05	CcSEcCtD
Donepezil—CYP2C9—Metabolism—SPHK1—hematologic cancer	9.28e-06	0.000143	CbGpPWpGaD
Donepezil—Dermatitis—Doxorubicin—hematologic cancer	9.27e-06	2.64e-05	CcSEcCtD
Donepezil—Headache—Doxorubicin—hematologic cancer	9.22e-06	2.63e-05	CcSEcCtD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CG—hematologic cancer	9.22e-06	0.000142	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SRC—hematologic cancer	9.17e-06	0.000141	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PARP1—hematologic cancer	9.11e-06	0.00014	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—UGT1A1—hematologic cancer	8.99e-06	0.000138	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.97e-06	0.000138	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FBXW7—hematologic cancer	8.96e-06	0.000138	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—hematologic cancer	8.94e-06	0.000138	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—UGT1A1—hematologic cancer	8.91e-06	0.000137	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTAP—hematologic cancer	8.87e-06	0.000137	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—STAT3—hematologic cancer	8.85e-06	0.000136	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NRAS—hematologic cancer	8.83e-06	0.000136	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCR4—hematologic cancer	8.79e-06	0.000135	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HDAC2—hematologic cancer	8.79e-06	0.000135	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC22A1—hematologic cancer	8.75e-06	0.000135	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CRABP1—hematologic cancer	8.75e-06	0.000135	CbGpPWpGaD
Donepezil—Nausea—Doxorubicin—hematologic cancer	8.74e-06	2.49e-05	CcSEcCtD
Donepezil—CYP2C9—Metabolism—CRABP1—hematologic cancer	8.67e-06	0.000133	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC22A1—hematologic cancer	8.67e-06	0.000133	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CBL—hematologic cancer	8.57e-06	0.000132	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CG—hematologic cancer	8.55e-06	0.000132	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALOX5—hematologic cancer	8.52e-06	0.000131	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL3—hematologic cancer	8.48e-06	0.00013	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK3—hematologic cancer	8.45e-06	0.00013	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALOX5—hematologic cancer	8.45e-06	0.00013	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CG—hematologic cancer	8.37e-06	0.000129	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTPN1—hematologic cancer	8.33e-06	0.000128	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NUP98—hematologic cancer	8.26e-06	0.000127	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PTPN11—hematologic cancer	8.23e-06	0.000127	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—hematologic cancer	8.22e-06	0.000127	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TGFB1—hematologic cancer	8.2e-06	0.000126	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RASGRP1—hematologic cancer	8.2e-06	0.000126	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NUP98—hematologic cancer	8.18e-06	0.000126	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SYK—hematologic cancer	8.17e-06	0.000126	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HSP90AA1—hematologic cancer	8.17e-06	0.000126	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CD—hematologic cancer	8.11e-06	0.000125	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ADCY7—hematologic cancer	8.01e-06	0.000123	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NCOA3—hematologic cancer	8.01e-06	0.000123	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CREB1—hematologic cancer	7.97e-06	0.000123	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NUP214—hematologic cancer	7.96e-06	0.000122	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ADCY7—hematologic cancer	7.94e-06	0.000122	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NCOA3—hematologic cancer	7.94e-06	0.000122	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CREBBP—hematologic cancer	7.93e-06	0.000122	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—FHL2—hematologic cancer	7.91e-06	0.000122	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NUP214—hematologic cancer	7.89e-06	0.000121	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT1—hematologic cancer	7.88e-06	0.000121	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.81e-06	0.00012	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCL2—hematologic cancer	7.8e-06	0.00012	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTR—hematologic cancer	7.8e-06	0.00012	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCG2—hematologic cancer	7.8e-06	0.00012	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6R—hematologic cancer	7.78e-06	0.00012	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AGRN—hematologic cancer	7.76e-06	0.000119	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTR—hematologic cancer	7.73e-06	0.000119	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCG2—hematologic cancer	7.73e-06	0.000119	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3R1—hematologic cancer	7.65e-06	0.000118	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ENO2—hematologic cancer	7.65e-06	0.000118	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KRAS—hematologic cancer	7.6e-06	0.000117	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ENO2—hematologic cancer	7.58e-06	0.000117	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CD—hematologic cancer	7.52e-06	0.000116	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—JAK2—hematologic cancer	7.44e-06	0.000114	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—hematologic cancer	7.42e-06	0.000114	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTT1—hematologic cancer	7.42e-06	0.000114	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAP2K1—hematologic cancer	7.41e-06	0.000114	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GRB2—hematologic cancer	7.37e-06	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CD—hematologic cancer	7.36e-06	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDGFA—hematologic cancer	7.35e-06	0.000113	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMMR—hematologic cancer	7.35e-06	0.000113	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—IDH2—hematologic cancer	7.35e-06	0.000113	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTT1—hematologic cancer	7.35e-06	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KITLG—hematologic cancer	7.25e-06	0.000112	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SDC1—hematologic cancer	7.25e-06	0.000112	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.24e-06	0.000111	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SDC1—hematologic cancer	7.18e-06	0.000111	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3R1—hematologic cancer	7.1e-06	0.000109	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT5A—hematologic cancer	7.09e-06	0.000109	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CB—hematologic cancer	7.07e-06	0.000109	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN2B—hematologic cancer	7.02e-06	0.000108	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CA—hematologic cancer	6.98e-06	0.000107	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3R1—hematologic cancer	6.95e-06	0.000107	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.91e-06	0.000106	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.86e-06	0.000106	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CD86—hematologic cancer	6.79e-06	0.000105	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.78e-06	0.000104	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—JAK2—hematologic cancer	6.76e-06	0.000104	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—hematologic cancer	6.75e-06	0.000104	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CA9—hematologic cancer	6.73e-06	0.000104	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ACP5—hematologic cancer	6.73e-06	0.000104	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HES1—hematologic cancer	6.7e-06	0.000103	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NCOR1—hematologic cancer	6.66e-06	0.000103	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.64e-06	0.000102	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGF1—hematologic cancer	6.59e-06	0.000101	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CSF2—hematologic cancer	6.59e-06	0.000101	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CB—hematologic cancer	6.55e-06	0.000101	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FOXO1—hematologic cancer	6.49e-06	9.99e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2—hematologic cancer	6.49e-06	9.99e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.48e-06	9.97e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDGFRB—hematologic cancer	6.48e-06	9.97e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HRAS—hematologic cancer	6.46e-06	9.94e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CB—hematologic cancer	6.42e-06	9.87e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDGFRA—hematologic cancer	6.38e-06	9.82e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JAK1—hematologic cancer	6.36e-06	9.78e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PRKCG—hematologic cancer	6.36e-06	9.78e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—IDH1—hematologic cancer	6.32e-06	9.73e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TXN—hematologic cancer	6.25e-06	9.62e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.25e-06	9.62e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.25e-06	9.62e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—hematologic cancer	6.18e-06	9.51e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NQO1—hematologic cancer	6.16e-06	9.48e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CD44—hematologic cancer	6.16e-06	9.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.12e-06	9.42e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NQO1—hematologic cancer	6.11e-06	9.4e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CD44—hematologic cancer	6.11e-06	9.4e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.98e-06	9.21e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2RA—hematologic cancer	5.94e-06	9.14e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2—hematologic cancer	5.89e-06	9.07e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.88e-06	9.05e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TERT—hematologic cancer	5.87e-06	9.04e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYCS—hematologic cancer	5.83e-06	8.97e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.79e-06	8.92e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYCS—hematologic cancer	5.78e-06	8.9e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.74e-06	8.84e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDGFB—hematologic cancer	5.73e-06	8.82e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.72e-06	8.8e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.72e-06	8.8e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—hematologic cancer	5.7e-06	8.77e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTEN—hematologic cancer	5.66e-06	8.71e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TSC2—hematologic cancer	5.6e-06	8.62e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.57e-06	8.58e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—EP300—hematologic cancer	5.4e-06	8.31e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NUP98—hematologic cancer	5.4e-06	8.31e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGFR3—hematologic cancer	5.39e-06	8.29e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK14—hematologic cancer	5.33e-06	8.21e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.24e-06	8.06e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.24e-06	8.06e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ESR1—hematologic cancer	5.23e-06	8.05e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NUP214—hematologic cancer	5.2e-06	8.01e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.17e-06	7.96e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FN1—hematologic cancer	5.17e-06	7.95e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—hematologic cancer	5.14e-06	7.91e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NFKBIA—hematologic cancer	5.11e-06	7.86e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BAD—hematologic cancer	5.11e-06	7.86e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTR—hematologic cancer	5.1e-06	7.84e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.1e-06	7.84e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—hematologic cancer	5.1e-06	7.84e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH1—hematologic cancer	5.06e-06	7.78e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ENO2—hematologic cancer	5e-06	7.69e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CD80—hematologic cancer	4.96e-06	7.63e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KIT—hematologic cancer	4.95e-06	7.61e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CG—hematologic cancer	4.95e-06	7.61e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—NRAS—hematologic cancer	4.95e-06	7.61e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.93e-06	7.59e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.87e-06	7.49e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTPN11—hematologic cancer	4.86e-06	7.48e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.85e-06	7.46e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.82e-06	7.42e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SDC1—hematologic cancer	4.74e-06	7.29e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAPK3—hematologic cancer	4.74e-06	7.29e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.72e-06	7.27e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.72e-06	7.27e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CREB1—hematologic cancer	4.71e-06	7.25e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.68e-06	7.21e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.68e-06	7.21e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BRAF—hematologic cancer	4.65e-06	7.16e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL2—hematologic cancer	4.61e-06	7.09e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6R—hematologic cancer	4.59e-06	7.07e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CREBBP—hematologic cancer	4.59e-06	7.06e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAP2K1—hematologic cancer	4.38e-06	6.74e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CD—hematologic cancer	4.35e-06	6.69e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CA—hematologic cancer	4.31e-06	6.63e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KRAS—hematologic cancer	4.26e-06	6.55e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.17e-06	6.42e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGF2—hematologic cancer	4.16e-06	6.41e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTHFR—hematologic cancer	4.14e-06	6.37e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3R1—hematologic cancer	4.11e-06	6.32e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CD44—hematologic cancer	4.03e-06	6.2e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NQO1—hematologic cancer	4.03e-06	6.2e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CA—hematologic cancer	3.99e-06	6.15e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JAK2—hematologic cancer	3.99e-06	6.14e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CA—hematologic cancer	3.91e-06	6.02e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MDM2—hematologic cancer	3.9e-06	6e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYCS—hematologic cancer	3.81e-06	5.87e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	3.79e-06	5.83e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MTOR—hematologic cancer	3.79e-06	5.83e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.79e-06	5.83e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.65e-06	5.61e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	3.62e-06	5.57e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	3.56e-06	5.47e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	3.52e-06	5.42e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.51e-06	5.4e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—hematologic cancer	3.49e-06	5.37e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2—hematologic cancer	3.48e-06	5.36e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.48e-06	5.35e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—hematologic cancer	3.46e-06	5.33e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCND1—hematologic cancer	3.39e-06	5.22e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JUN—hematologic cancer	3.39e-06	5.21e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.36e-06	5.17e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	3.28e-06	5.05e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTEN—hematologic cancer	3.28e-06	5.04e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—hematologic cancer	3.26e-06	5.02e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.25e-06	5e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.22e-06	4.96e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	3.2e-06	4.93e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	3.2e-06	4.92e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.18e-06	4.9e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EP300—hematologic cancer	3.12e-06	4.81e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.09e-06	4.75e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.09e-06	4.75e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.08e-06	4.74e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.06e-06	4.7e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—hematologic cancer	3.04e-06	4.68e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SRC—hematologic cancer	3.04e-06	4.67e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—hematologic cancer	3.02e-06	4.64e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	2.96e-06	4.55e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT3—hematologic cancer	2.93e-06	4.51e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NRAS—hematologic cancer	2.92e-06	4.5e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.91e-06	4.48e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.89e-06	4.44e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	2.8e-06	4.31e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.73e-06	4.2e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—hematologic cancer	2.72e-06	4.19e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	2.72e-06	4.18e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.69e-06	4.14e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.66e-06	4.1e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KRAS—hematologic cancer	2.52e-06	3.87e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTEN—hematologic cancer	2.32e-06	3.57e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	2.31e-06	3.56e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTEN—hematologic cancer	2.3e-06	3.54e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.29e-06	3.53e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—hematologic cancer	2.24e-06	3.44e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—EP300—hematologic cancer	2.21e-06	3.41e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—EP300—hematologic cancer	2.2e-06	3.38e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRAS—hematologic cancer	2.14e-06	3.29e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.13e-06	3.27e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—hematologic cancer	2.05e-06	3.15e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.02e-06	3.1e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—hematologic cancer	1.99e-06	3.06e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.9e-06	2.93e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.89e-06	2.9e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.76e-06	2.7e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.64e-06	2.52e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.62e-06	2.5e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTEN—hematologic cancer	1.52e-06	2.34e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—EP300—hematologic cancer	1.45e-06	2.23e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—hematologic cancer	1.34e-06	2.06e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—hematologic cancer	1.33e-06	2.04e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.07e-06	1.65e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—hematologic cancer	8.75e-07	1.35e-05	CbGpPWpGaD
